Tabatha Hawkins
Nurse Practitioner · Louisville, KYNPI 1134766603
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 24.9% of the total. Reporting peaked in 2023 at $1,098 and has fallen 62.3% since, to $414 in 2025.
Across 120 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$503
- Otsuka America Pharmaceutical, Inc.$206
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$198
- Vanda Pharmaceuticals Inc.$181
- Almatica Pharma LLC$154
- Braeburn Inc.$145
- plus $630 from 11 others
What the payments were for
- Food & beverage$2,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $503 |
| Otsuka America Pharmaceutical, Inc. | 7 | $206 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $198 |
| Vanda Pharmaceuticals Inc. | 4 | $181 |
| Almatica Pharma LLC | 14 | $154 |
| Braeburn Inc. | 7 | $145 |
| Indivior Inc. | 7 | $130 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| Lundbeck LLC | 4 | $71 |
| Corium, LLC | 5 | $70 |
| Idorsia Pharmaceuticals US Inc | 4 | $56 |
| Alkermes, Inc. | 3 | $49 |
| USWM, LLC | 3 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Gilead | 1 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fanapt$125
How this compares
$2,017 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 108 | $8,815 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $324 |
| Ondansetron Hcl | 11 | $75 |
| Clonazepam | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Louisville
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Rebecca BraunerLouisville$40K
- Thomas FreelsLouisville$20K
- Christy BakerLouisville$18K
- Blair WagnerLouisville$15K
- Kathryn WestLouisville$13K
- Kimberly RobinsonLouisville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.